Abstract
The standardization and data sharing of genomic and phenotypic data for big data analysis in cancer genome medicine has become important. In particular, the number of genomic data being sequenced within the framework of medicine is increasing rapidly, and responsible sharing of clinical sequence data is a challenge. I outline new schemes for sharing genomic and phenotypic data, such as cloud computing, data access control through authentication, new forms of exchange of phenotypic information, and standardization of genomic data through clinical sequencing.
